Fox Run Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-12,084
Closed -$183K – 1143
2025
Q4
$183K Buy
+12,084
New +$184K 0.03% 815
2025
Q1
– Sell
-18,748
Closed -$327K – 1134
2024
Q4
$327K Buy
+18,748
New +$326K 0.06% 601
2024
Q2
– Sell
-14,070
Closed -$204K – 983
2024
Q1
$204K Sell
14,070
-15,731
-53% -$217K 0.04% 627
2023
Q4
$402K Buy
+29,801
New +$350K 0.1% 376

Other funds holding OFIX

Fox Run Management's OFIX Position: Q1 2026 in Review

Fox Run Management sold out of Orthofix Medical (OFIX) in Q1 2026, closing a stake of 12,084 shares — an estimated $183K sold.

Fox Run Management first reported a position in OFIX in Q4 2023 and held it in 4 quarters. The position peaked at $402K in Q4 2023. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Fox Run Management reported no remaining Orthofix Medical position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 12,084 Orthofix Medical shares in Q1 2026, an estimated $183K.
  • Fox Run Management first reported a position in Orthofix Medical in Q4 2023 and held it in 4 quarters.
  • Fox Run Management's Orthofix Medical position peaked at $402K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.